151
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

sCD48 is elevated in non-allergic but not in allergic persistent rhinitis

, , &
Pages 724-730 | Received 03 Feb 2021, Accepted 22 Aug 2021, Published online: 03 Sep 2021

References

  • Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58(Suppl S29):1–464.
  • Bousquet J, Van Cauwenberge P, Khaltaev N, et al. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108:147–334.
  • Brożek JL, Bousquet J, Agache I, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol. 2017;140(4):950–958.
  • Wise SK, Lin SY, Toskala E, et al. International consensus statement on allergy and rhinology: allergic rhinitis. Int Forum Allergy Rhinol. 2018;8(2):108–352.
  • Demoly P, Allaert FA, Lecasble M, et al. Validation of the classification of ARIA (allergic rhinitis and its impact on asthma). Allergy. 2003;58(7):672–675.
  • Hellings PW, Klimek L, Cingi C, et al. Non-allergic rhinitis: position paper of the European academy of allergy and clinical immunology. Allergy. 2017;72(11):1657–1675.
  • Cazzoletti L, Ferrari M, Olivieri M, et al. The gender, age and risk factor distribution differs in self-reported allergic and non-allergic rhinitis: a cross-sectional population-based study. Allergy Asthma Clin Immunol. 2015;11(1):36.
  • Olsson P, Berglind N, Bellander T, et al. Prevalence of self-reported allergic and non-allergic rhinitis symptoms in Stockholm: relation to age, gender, olfactory sense and smoking. Acta Otolaryngol. 2003;123(1):75–80.
  • Rondon C, Campo P, Togias A, et al. Local allergic rhinitis: concept, pathophysiology, and management. J Allergy Clin Immunol. 2012;129(6):1460–1467.
  • Papadopoulos NG, Bernstein JA, Demoly P, et al. Phenotypes and endotypes of rhinitis and their impact on management: a PRACTALL report. Allergy. 2015;70(5):474–494.
  • McArdel SL, Terhorst C, Sharpe AH. Roles of CD48 in regulating immunity and tolerance. Clin Immunol. 2016;164:10–20.
  • Elishmereni M, Alenius HT, Bradding P, et al. Physical interactions between mast cells and eosinophils: a novel mechanism enhancing eosinophil survival in vitro. Allergy. 2011;66(3):376–385.
  • Munitz A, Bachelet I, Eliashar R, et al. CD48 is an allergen and IL-3-induced activation molecule on eosinophils. J Immunol. 2006;177(1):77–83.
  • Ha SG, Ge XN, Bahaie NS, et al. ORMDL3 promotes eosinophil trafficking and activation via regulation of integrins and CD48. Nat Commun. 2013;4:2479.
  • Wuttge DM, Andreasson A, Tufvesson E, et al. CD81 and CD48 show different expression on blood eosinophils in systemic sclerosis: new markers for disease and pulmonary inflammation? Scand J Rheumatol. 2016;45(2):107–113.
  • Smith GM, Biggs J, Norris B, et al. Detection of a soluble form of the leukocyte surface antigen CD48 in plasma and its elevation in patients with lymphoid leukemias and arthritis. J Clin Immunol. 1997;17(6):502–509.
  • Munitz A, Bachelet I, Finkelman FD, et al. CD48 is critically involved in allergic eosinophilic airway inflammation. Am J Respir Crit Care Med. 2007;175(9):911–918.
  • Branicka O, Jura-Szołtys E, Rogala B, et al. Elevated serum level of CD48 in patients with intermittent allergic rhinitis. Int Arch Allergy Immunol. 2020;23:1–10.
  • Bousquet J, Heinzerling L, Bachert C, et al. Practical guide to skin prick tests in allergy to aeroallergens. Allergy. 2012;67(1):18–24.
  • American Thoracic Society, European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am J Respir Crit Care Med. 2005. 2005;171:912–930.
  • Katsuura M, Shimizu Y, Akiba K, et al. CD48 expression on leukocytes in infectious diseases: flow cytometric analysis of surface antigen. Acta Paediatr Jpn. 1998;40(6):580–585.
  • Muñoz S, Hernández-Pando R, Abraham SN, et al. Mast cell activation by Mycobacterium tuberculosis: mediator release and role of CD48. J Immunol. 2003;170(11):5590–5596.
  • Malaer JD, Marrufo AM, Mathew PA. 2B4 (CD244, SLAMF4) and CS1 (CD319, SLAMF7) in systemic lupus erythematosus and cancer. Clin Immunol. 2019;204:50–56.
  • Gangwar RS, Minai-Fleminger Y, Seaf M, et al. CD48 on blood leukocytes and in serum of asthma patients varies with severity. Allergy. 2017;72(6):888–895.
  • Gröger M, Klemens C, Wendt S, et al. Mediators and cytokines in persistent allergic rhinitis and nonallergic rhinitis with eosinophilia syndrome. Int Arch Allergy Immunol. 2012;159(2):171–178.
  • König K, Klemens C, Eder K, et al. Cytokine profiles in nasal fluid of patients with seasonal or persistent allergic rhinitis. Allergy Asthma Clin Immunol. 2015;11(1):26.
  • El-Naggar M, Saleh AB, Salam Ahmed MA, et al. The C–C chemokines, RANTES and eotaxin, in atopic dermatitis, atopic asthmatics and allergic rhinitis patients: relation to Disease Severity, Egypt. J. Med. Microbiol. 2008;17:265–278.
  • Brescia G, Barion U, Zanotti C, et al. The prognostic role of serum eosinophil and basophil levels in sinonasal polyposis. Int Forum Allergy Rhinol. 2017;7(3):261–267.
  • Parrino D, Brescia G, Zanotti C, et al. Non-eosinophilic chronic rhinosinusitis with nasal polyps: eosinophil, basophil, and neutrophil blood counts before and after surgery. Ann Otol Rhinol Laryngol. 2019;128(3):233–240.
  • Brescia G, Franz L, Alessandrini L, et al. Prognostic role of blood eosinophil and basophil levels in allergic fungal rhinosinusitis (AFRS). Am J Otolaryngol. 2020;41(1):102301.
  • Meng Y, Lou H, Wang Y, et al. Endotypes of chronic rhinitis: a cluster analysis study. Allergy. 2019;74(4):720–730.
  • Muntean IA, Bocsan IC, Vesa S, et al. Could FeNO predict asthma in patients with house dust mites allergic rhinitis? Medicina. 2020;56(5):235.
  • Yalcin AD, Uçar S, Gumuslu S, et al. Effects of omalizumab on eosinophil cationic peptide, 25-hydroxyvitamin-D, IL-1β and sCD200 in cases of Samter’s syndrome: 36 months follow-up. Immunopharmacol Immunotoxicol. 2013;35(4):524–527.
  • Vo-Thi-Kim A, Van-Quang T, Nguyen-Thanh B, et al. The effect of medical treatment on nasal exhaled nitric oxide (NO) in patients with persistent allergic rhinitis: a randomized control study. Avd Med Sci. 2020;65(1):182–188.
  • Göker AE, Ekincioglu E, Alagöz MH, et al. The association of allergic rhinitis severity with neutrophil-lymphocyte and platelet-lymphocyte ratio in adults. Eur Arch Otorhinolaryngol. 2019;276(12):3383–3388.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.